Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Mayo Clin Proc. 2008 Sep;83(9):1032–1045. doi: 10.4065/83.9.1032

TABLE 1. Relative Risk Reduction for Vertebral, Hip, or Nonvertebral Fractures in Postmenopausal Women With Known Osteoporosis After 3 Years of Daily Oral Bisphosphonate Treatment.

a

Bisphosphonate
Type of fracture Risedronate26,27 Alendronate24 Ibandronate30
Vertebral 41 47 62
Hip 40 51 NS
Nonvertebral 39 20 NS
a

NS = not significant.